JPS5569510A - Carcinostatic agent - Google Patents
Carcinostatic agentInfo
- Publication number
- JPS5569510A JPS5569510A JP14168378A JP14168378A JPS5569510A JP S5569510 A JPS5569510 A JP S5569510A JP 14168378 A JP14168378 A JP 14168378A JP 14168378 A JP14168378 A JP 14168378A JP S5569510 A JPS5569510 A JP S5569510A
- Authority
- JP
- Japan
- Prior art keywords
- carcinostatic agent
- chlorobenzaldehyde
- fluorobenzaldehyde
- nitrobenzaldehyde
- injection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
PURPOSE: To provide a carcinostatic agent effective to the scirrhous cancer, containing at least one benzaldehyde derivative selected from p-nitrobenzaldehyde, p- fluorobenzaldehyde and m-chlorobenzaldehyde.
CONSTITUTION: A composition containging at least one benzaldehyde derivative selected from p-nitrobenzaldehyde, p-fluorobenzaldehyde and m-chlorobenzaldehyde. Administered by intravenous injection, subcutaneous injection, or oral administration in the form of a capsule. Dose: 5W100mg/kg for adult as an aqueous solution (for injection), and 20W500mg/kg by oral administration.
COPYRIGHT: (C)1980,JPO&Japio
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14168378A JPS5569510A (en) | 1978-11-16 | 1978-11-16 | Carcinostatic agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14168378A JPS5569510A (en) | 1978-11-16 | 1978-11-16 | Carcinostatic agent |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS5569510A true JPS5569510A (en) | 1980-05-26 |
Family
ID=15297771
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP14168378A Pending JPS5569510A (en) | 1978-11-16 | 1978-11-16 | Carcinostatic agent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5569510A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994007479A2 (en) * | 1992-10-01 | 1994-04-14 | The Wellcome Foundation Limited | Immunopotentiatory agents |
JP2017506665A (en) * | 2014-02-26 | 2017-03-09 | ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム | Nitrobenzaldehyde proton release method for manipulation of cellular acidosis |
-
1978
- 1978-11-16 JP JP14168378A patent/JPS5569510A/en active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994007479A2 (en) * | 1992-10-01 | 1994-04-14 | The Wellcome Foundation Limited | Immunopotentiatory agents |
WO1994007479A3 (en) * | 1992-10-01 | 1994-07-21 | Wellcome Found | Immunopotentiatory agents |
JP2017506665A (en) * | 2014-02-26 | 2017-03-09 | ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム | Nitrobenzaldehyde proton release method for manipulation of cellular acidosis |
CN107073119A (en) * | 2014-02-26 | 2017-08-18 | 德克萨斯大学***董事会 | Release for the nitrobenzaldehyde proton of manipulation cell acid poisoning |
US10946096B2 (en) | 2014-02-26 | 2021-03-16 | The Board Of Regents Of The University Of Texas System | Nitrobenzaldehyde proton release for manipulation of cellular acidosis |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS5225013A (en) | Insulin pharmaceutical for nasal administration | |
JPS5551020A (en) | Remedy for rheumatism | |
JPS5332124A (en) | Carcinostatic agent | |
JPS56138111A (en) | Suppository containing unsaturated fatty acid or salt thereof | |
JPS57109721A (en) | Carcinostatic agent | |
JPS52108028A (en) | Remedies for dysacousis | |
JPS5569510A (en) | Carcinostatic agent | |
JPS5630917A (en) | Preventive and remedy for hepatitis | |
JPS56138110A (en) | Suppository containing citric acid or salt thereof | |
JPS5470428A (en) | Carcinostatic agent | |
JPS56115715A (en) | Physiologically active agent containing (3- dimethylcarbam-oxyphenyl) trimethyl ammonium derivative | |
JPS53148518A (en) | Stabilized prostaglandin e composition and its preparation | |
JPS57114512A (en) | Antidia beticagent comprising (3-dimethyl-carbamoxy- phenyl)trimethyl ammonium derivative | |
JPS55122721A (en) | Antidiabetic agent | |
JPS54132239A (en) | Anti-tumor agent | |
JPS56138112A (en) | Suppository containing ascorbic acid or sodium ascorbate | |
JPS5675428A (en) | Hypoglycemic agent containing procainamide hydrochloride | |
JPS5498339A (en) | Carcinostatic agent | |
JPS5484034A (en) | Anti-tumor agent | |
JPS54125663A (en) | Carcinostatic agent and novel compound having carcinostatic activity | |
JPS51136818A (en) | Method for preparing stable prostaglandine pharma ceuticals | |
JPS5251362A (en) | Preparation of optically active pyrrolidine derivatives | |
JPS52130906A (en) | Stable solution of uracil derivative | |
JPS57126422A (en) | Stabilizing method of lysozyme pharmaceutical | |
JPS5742620A (en) | Novel antiulcer agent |